Hassabani and Karam Host Safety Standards Workshop

A Lebanese workshop discussed the regulation of registration, import, and handling of biosimilar medicines, aiming to establish a clear legislative framework to protect patients and ensure the safety, quality, and efficacy of these medications. The proposals were based on international references such as the World Health Organization, the European Medicines Agency, and the U.S. Food and Drug Administration. They emphasize that scientific standards should be mandatory and adaptable without compromising patient safety. The workshop also highlighted the importance of tracking and transparency systems to monitor the safety of medicines after they enter the market, ensuring a balance between expanding access to treatment and maintaining the highest standards of quality and safety.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل